Yun-Xiang Tang
Overview
Explore the profile of Yun-Xiang Tang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
71
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li Z, Qin Y, Cai W, Deng S, Mao X, Zhang J, et al.
Nat Sci Sleep
. 2023 Sep;
15:729-736.
PMID: 37753520
Purpose: This study aims to examine the impact of sleep deprivation on individual cognitive reappraisal ability using a standardized behavioral paradigm. Methods: A randomized pretest-posttest control group design was conducted....
2.
Xiao B, Su T, Huang Y, Lin G, Liu Z, Tang Y, et al.
Support Care Cancer
. 2021 Nov;
30(3):2445-2453.
PMID: 34775535
Purpose: As an antipsychotic agent that targets multiple neurotransmitter receptors, olanzapine has been added to antiemetic therapies. For better understanding the application of olanzapine in antiemetic strategies for breast cancer...
3.
He J, Tu Z, Xiao L, Su T, Tang Y
PLoS One
. 2020 Feb;
15(2):e0228756.
PMID: 32040492
Background: This study aimed to assess the effects of restricting mobile phone use before bedtime on sleep, pre-sleep arousal, mood, and working memory. Methods: Thirty-eight participants were randomized to either...
4.
Zhang N, Tang Y, Qian L, Gao Y, Liu Z, Zou Z, et al.
Arch Pharm (Weinheim)
. 2019 Jan;
352(4):e1800277.
PMID: 30698293
A series of novel 3-amidophenols with 5-heteroatomic substitutions were designed and synthesized. Several compounds showed potent antitubercular activity against Mycobacterium tuberculosis H37Ra (MIC = 0.25-5 μg/mL). Compounds 12j and 14i...
5.
Liang J, Tang Y, Tang X, Liang H, Gao Y, Fang C, et al.
Chem Pharm Bull (Tokyo)
. 2019 Jan;
67(4):372-381.
PMID: 30686792
A series of meta-amido bromophenol derivatives were designed and synthesized. The compounds were found to potently inhibit the growth of Mycobacterium tuberculosis H37Ra. They also exhibited moderate inhibitory activity against...
6.
Zhang N, Liu Z, Liang J, Tang Y, Qian L, Gao Y, et al.
Medchemcomm
. 2018 Aug;
9(8):1293-1304.
PMID: 30151083
A series of -amidophenol derivatives (, , , , , and ) were designed and synthesized. Their antitubercular activities were evaluated against strains H37Ra and H37Rv and clinically isolated multidrug-resistant...
7.
Wei Y, Lin W, Zhang T, Tang Y, Wang J, Zhong M
Sci Rep
. 2018 Apr;
8(1):6230.
PMID: 29670200
Although recent studies focused on traditional Chinese medicine (TCM) for the treatment of refractory schizophrenia have reported that it may be beneficial, there is still lack of convincing evidence and...
8.
Wei Y, Wang J, Yan C, Li Z, Pan X, Cui Y, et al.
Chin Med J (Engl)
. 2016 Feb;
129(5):578-85.
PMID: 26904993
Background: Several studies using functional magnetic resonance imaging (fMRI) and positron emission tomography (PET) have indicated that cognitive remediation therapy (CRT) might improve cognitive function by changing brain activations in...
9.
Qiu Y, Tang Y, Chan R, Sun X, He J
PLoS One
. 2014 Jun;
9(6):e97794.
PMID: 24933577
Background: Decreased P300 amplitude is one of the most consistent findings in patients with schizophrenia. However, whether prolonged P300 latency occurs in patients with schizophrenia, especially first-episode schizophrenia (FES) patients,...
10.
Qiu Y, Tang Y, He J
Zhonghua Yi Xue Za Zhi
. 2014 Jan;
93(41):3261-4.
PMID: 24401618
Objective: To explore the diagnostic application of receiver operating characteristic (ROC) curve of P300 amplitude and latency in schizophrenia. Methods: ROC curve of P300 amplitude and latency was plotted from...